The Use of Intranasal Ketoralac for Pain Management (Sprix)

NCT01736358 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Interim analysis showed futility of primary endpoint

Conditions

Postoperative Pain Management
Urolithiasis

Interventions

DRUG: Intranasal Ketoralac
DRUG: Placebo

Sponsor

Montefiore Medical Center